We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Biomedical Textiles Signify Breakthrough in Healthcare Management

By HospiMedica International staff writers
Posted on 06 Nov 2012
Biomedical textiles that enable the autonomy and mobility of patients while wirelessly monitoring their vital signs hold huge potential across different application segments. More...
These are the latest findings of Frost & Sullivan (Mountain View, CA, USA), an international market research firm.

The combination of health monitoring devices with textiles carries the benefits of patient safety, enhanced comfort to users, and undisputed economic viability. As a result, research groups around the world are developing textiles that are adaptable to different bodily fluids and chronic disease profiles, wherein the textile itself acts as the biosensor, providing diagnostic information that improves early detection rates, as well as cost-effective ambulatory care to patients with chronic disorders.

The main challenge underlying the development of biomedical textiles lays in realizing its intended potential, but with the accelerated pace of innovation in the device industry, textile engineers are validating their findings on woven structures, allowing them to expand their design portfolio to incorporate performance characteristics. But careful consideration is required when designing smart textile products to ensure the inclusion of smart fabric components does not push the price point of wearable clothing beyond the reach of everyday consumers.

One of the major drives for the adoption of biomedical textiles comes from the fact that both end-users and medical professionals alike are stressing novel monitoring approaches that reduce the risks associated with diabetes, cardiac arrest, hypertension, and stroke, among others. Wearable textiles allow for the monitoring of patients constantly, which creates the impetus for creating smarter and intelligent textiles. The resulting miniaturization of various systems and the issue of biocompatibility of fabrics across bodily fluids have driven various corporate and research lab innovations to arise in this segment.

“Extensive research efforts are being put towards developing effective integration techniques that amalgamate ideal biosensors into textile materials. This step requires expertise in the fields of materials, electronics, and textiles,” said Frost & Sullivan industry analyst Prasanna Vadhana Kannan. “The increasing health awareness and patient focus has shifted towards prevention, allowing monitoring to emerge as a major driving force for the biomedical textiles industry. The plethora of applications continues to increase in diversity with new innovations."

Related Links:

Frost & Sullivan



Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Radiation Safety Barrier
RayShield Intensi-Barrier
LED Surgical Lamp
ACEMST35/57
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.